Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
If a plan denies coverage citing that GLP-1s arent covered for obesity, families can appeal under EPSDT, the plan must evaluate medical necessity rather than blanket-deny based on drug category
Patient age, diabetes duration, and background treatment were evaluated, and no significant effect on the primary outcomes was found (appendix 12)
Lovshin JA, Drucker DJ
NotCos AI technology allowed the company to rapidly iterate millions of possible formulations, optimizing the desired outcomes to reach a final formulation
US$ 24.98
US$ 22.91
US$ 27.30
US$ 20.75
US$ 20.22
